Xavier Leleu is Professor, Head of the Myeloma Clinic and Head of the Department of Haematology at Hôpital La Mileterie, part of the academic hospital of Poitiers (Centre Hospitalier Universitaire), Poitiers, France.
Professor Leleu received his medical degree at the University of Bordeaux, France. He completed his specialisation in public healthcare and statistics at the University of Medicine of Paris, France and in haematology at the University of Medicine of Lille. Professor Leleu was the head of the Myeloma Clinic in Lille under Professor T Facon’s mentorship for almost 15 years. He received a Master’s degree in cellular biology at the University of Medicine of Lille in 2001 and completed his PhD in 2007, having studied at Dana-Farber Cancer Institute, affiliated with Harvard Medical School, Boston, MA, USA. His main topic of research was the preclinical development of novel agents and understanding mechanisms of resistance and of dormancy in Waldenström macroglobulinaemia and the clinical development of novel agents in multiple myeloma in the context of the most recent discoveries in the biology of myeloma. He was trained with his mentors Dr IM Ghobrial and Dr SP Treon in Prof. Kenneth Anderson’s laboratory.
Professor Leleu’s current research is focused on the biology and treatment of multiple myeloma, Waldenström’s macroglobulinaemia and amyloidosis and he has published widely in these areas.
Professor Leleu is actively involved in numerous national and international clinical trials as investigator and coordinator. He is also a frequent speaker at national and international congresses and is a reviewer or a member of the editorial board of several haematology journals. He is currently serving on the board of directors of the Intergroupe Francophone du Myélome, and is also a member of a number of other national and international scientific societies.
EM-57260 - Date of preparation: March 2021